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Eighty-six Nocardia strains isolated from clinical samples in Belgium were identified by 16S rRNA gene
sequencing. Eighty-three (96%) strains belonged to only six Nocardia species: N. farcinica (38 [44%]), N. nova
(19 [22%]), N. cyriacigeorgica (13 [15%]), N. brasiliensis (6 [6.9%]), N. abscessus (5 [5.8%]), and N. paucivorans
(2 [2.3%]). A gallery of nine conventional and enzymatic tests was developed for the rapid identification of the
most common species isolated during this survey. Pyrrolidonyl aminopeptidase, -glutamyl aminopeptidase,
-mannosidase, and -glucosidase were found to be highly discriminating and could be used to develop an
identification scheme.
Nocardia species are isolated with an increased frequency
from clinical specimens, especially in specimens from immu-
nocompromised patients (19). The taxonomy of the genus has
dramatically been revised during the last decade, and at least
30 valid species have been reported, besides a number of un-
named genomospecies (18). Not all of them have been found
in humans, and Nocardia asteroides, previously most frequently
isolated from clinical specimens, has proved to be heteroge-
neous and has been divided into several species (18). More
recently, additional species of human origin have been de-
scribed (6, 8, 9, 11, 12, 17, 28).
The routine identification of Nocardia strains at the species
level is difficult in the laboratory. This, and the nomenclature
changes, may explain that species distribution in clinical iso-
lates has been poorly documented up to now, and even recent
surveys still report the “N. asteroides complex” as the most
frequent Nocardia species isolated in humans (7, 10, 16, 19).
Identification studies have not been systematically carried out
since the several recent taxonomic changes.
The aim of this study was to assess the species distribution of
a large number of Nocardia isolates and to propose simple and
rapid identification tests that may be helpful to identify the
species most commonly encountered in clinical material.
MATERIALS AND METHODS
Bacterial strains. Eighty-six Nocardia strains isolated from clinical specimens
in Belgium were collected for the study. Most strains were isolated during the
past decade, but a few were received before 1990. They were isolated by several
laboratories in different parts of the country. All the Nocardia isolates were
included in the study to avoid any bias in the selection of the strains. Only one
strain per patient was considered. The clinical origins of the isolates were as
follows: 36 strains were isolated from the respiratory tract, 18 from pyogenic
lesions and wounds, 8 from blood, 4 from brain abscesses, and 1 from cerebral
fluid. Nineteen were of unknown origin.
The type strains of the most relevant species were included for phenotypic
comparison as well as reference strains of some less common species. Nocardia
species and strains are listed in Table 1.
Sequencing of the 16S rRNA gene. The full-length 16S rRNA gene sequences
(1,400 nucleotides) of all strains were determined as described previously (24),
and sequences were compared to those of the type strains deposited in the Gen-
Bank database.
Cellular fatty acids were analyzed by gas-liquid chromatography as outlined
elsewhere (22).
Phenotypic characterization. Strains were cultured on tryptic soy blood agar
plates at 35°C. They were examined for partial acid-fastness, presence of aerial
hyphae, and resistance to lysozyme. Conventional tests for species identification,
including tyrosine, xanthine, and hypoxanthine decomposition, growth at 45°C,
and gelatin hydrolysis, were also performed (3). Furthermore, the following tests
were used in this study.
(i) Urea hydrolysis. For urea hydrolysis, a heavy loopful of bacteria was
suspended in 0.5 ml of a medium containing 1 g urea and 1 ml of a cresol red
solution (0.5% [wt/vol]) in 100 ml phosphate buffer (0.005 M) (pH 6). Tubes
were incubated at 35°C and examined after 1 and 2 days for a pink color shift
indicating a positive reaction.
(ii) Casein hydrolysis. Casein hydrolysis was detected on plates containing
10% (vol/vol) skim milk in nutrient agar. A heavy streak or spot was inoculated,
and plates were incubated at 35°C for 7 days. Clearing around the streak indi-
cated a positive reaction.
(iii) Acid production from rhamnose. Acid production from rhamnose was
detected on low-peptone phenol red (LPPR) agar with 1% rhamnose as previ-
ously described for ethylene glycol acidification (25).
(iv) Citrate alkalinization. Citrate alkalinization was performed on Simmons
citrate agar. Slants were heavily inoculated with organisms grown on blood agar.
Cultures were incubated at 35°C and examined daily for 5 days. Citrate utiliza-
tion with alkali production resulted in a blue color of the slant.
(v) -Glucosidase activity. -Glucosidase activity was detected by the use of
tablets containing the nitrophenyl conjugate of -D-glucopyranoside (Rosco,
Taastrup, Denmark). A heavy loopful of bacteria was suspended in 0.5 ml
distilled water and dispersed as much as possible. No attempt was made to obtain
a homogeneous suspension. The suspension with the reagent tablet was incu-
bated at 35°C and read after 4 h. When -glucosidase was present, the suspen-
sion turned yellow. When results were negative, the reaction was read again after
overnight incubation.
(vi) -Mannosidase. -Mannosidase was detected in the same way, using
nitrophenyl--D-mannopyranoside tablets (Rosco). Results were read after 4 h
of incubation.
(vii) PYR and -GLU. A heavy bacterial suspension was made in 0.5 ml
distilled water for each test as for -glucosidase. For the pyrrolidonyl amino-
peptidase (PYR) and -glutamyl aminopeptidase (-GLU) tests, substrate tab-
lets of pyrrolidonyl-naphthylamide and -glutamyl-naphthylamide (Rosco) were
added to the suspensions, respectively. After 4 h of incubation at 35°C, 1 drop of
cinnamaldehyde reagent was added. A color shift to orange or pink indicated a
positive reaction. The suspension remained yellow when the test was negative.
API ID 32 C strips (bio-Me´rieux, Marcy l’Etoile, France) was also used for
several strains.
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Antibiotic susceptibility tests for diagnostic purpose were performed to deter-
mine susceptibility patterns (21).
RESULTS
All strains exhibited partial acid-fastness, varying from weak
to strong. Aerial hyphae were observed at least once in all
strains, and growth was observed in the presence of lysozyme.
The main cellular fatty acids were 16:0, 18:19cis, 18:0, and
tuberculostearic acid, consistent with the pattern of Nocardia
species. On the basis of these properties, the strains were
presumably considered members of the genus Nocardia.
Sequencing of the 16S rRNA gene. The full-length sequences
of almost all the strains showed a similarity rate of 99.8% to
100% with a named species of the genus Nocardia compared to
the sequences of the GenBank database. One N. farcinica
strain displayed only 99.2% homology, one N. brasiliensis
99.6%, one N. cyriacigeorgica 99.7%, and one N. nova 99.7%
with the sequence of the respective type strain, but the phe-
notypic characteristics of these strains were consistent with
those of the corresponding species.
The distribution of the species among the 86 clinical isolates,
as determined by 16S rRNA gene sequencing (GenBank ac-
cession numbers within parentheses), was as follows: 38 (44.1%)
N. farcinica (AF430033), 19 (22.0%) N. nova (AF430028), 13
(15.1%) N. cyriacigeorgica (AF430027), 6 (6.9%) N. brasiliensis
(AF430038), 5 (5.8%) N. abscessus (AF430018), 2 (2.3%)
N. paucivorans (AF179865), 1 (1.1%) N. carnea (AF430035),
1 (1.1%) N. niigatensis (AB092565), and 1 (1.1%) N. asiatica
(AB162796).
Eighty-three strains (96.5%) belonged to only six species
represented by at least two isolates. Only three strains each
(3.5%) belonged to three less common species.
The clinical origin of the N. farcinica and N. nova isolates
was very diversified. It is noteworthy that seven of the eight
blood isolates and the four brain abscess strains were N. far-
cinica, which is considered by several authors as the most
invasive Nocardia species (19, 20). All but two strains of
N. cyricigeorgica were isolated from the respiratory tract. All
N. brasiliensis strains were found only in superficial abscesses
or wounds, in agreement with previous reports (19). The three
documented strains of N. abscessus were from wounds or pus
collections. The two N. paucivorans strains, as well as the
N. niigatensis and N. carnea strains, were isolated from the
respiratory tract. N. asiatica was found in a wound swab.
The clinical isolates were first examined by the conventional
hydrolysis test of xanthine, hypoxanthine, and tyrosine. All these
tests were negative except for tyrosine and hypoxanthine for
the six N. brasiliensis strains.
Nine tests were selected because the results were achieved in
a short time from 4 h to 1 or 2 days. Results of the 86 clinical
isolates and those of the reference strains are reported in Ta-
ble 1. As can be seen, most tests have a 100% or 0% positivity
rate, resulting in a high discrimination of the six main species
isolated in this study. It should be noted that test results of
species represented by a small number of strains should not be
considered definitive until more isolates are examined in the
future.
Urea hydrolysis varies considerably depending on medium
composition, inoculum size, and incubation time. This may
explain some discrepancies in the literature reports (18, 26,
TABLE 1. Biochemical test results of the 86 study strains and Nocardia reference strainsa
Species Strain(s) No. ofstrains
Growth
at 45°C Casein Urease Rhamnose
b Citratec PYR -GLU -Gluco-sidase
-Manno-
sidase
N. farcinica DSM 43665T         
Clinical strains 38 37 0 37 37 0 38 38 38 0
N. nova DSM 43207T         
Clinical strains 19 3 0 10 0 0 19 0 19 0
N. cyriacigeorgica DSM 44484T         
Clinical strains 13 13 0 0 0 0 0 13 13 0
N. brasiliensis NCTC 11294T  d       
Clinical strains 6 0 6d 6 0 0 0 6 6 6
N. abscessus DSM 44432T    w     
Clinical strains 5 0 0 5 0 5 0 5 5 0
N. paucivorans DSM 44386T         
Clinical strains 2 2 0 0 0 0 0 2 0 0
N. asiatica DSM 44668T         
Clinical strain 1 0 0 1 1 1 0 1 1 0
N. niigatensis DSM 44670T         
Clinical strain 1 0 0 0 0 0 1 0 1 0
N. camea DSM 43397T, 44558, 46071         
Clinical strain 1 0 0 0 1 0 0 1 0 0
N. otitidiscaviarum NCTC 1934T         
N. africana DSM 44491T         
N. veterana DSM 44445T         
N. puris DSM 44599T         
N. transvalensis DSM 43405T     w    
N. pseudobrasiliensis DSM 44290T  e       
N. asteroides NCTC 11293T, DSM 43258         
a Test results for type strains are shown as follows: , positive; w, weak reaction; , negative. For clinical strains, the number of positive strains is shown.
b Acid production from rhamnose within 1 day.
c Citrate alkalinization on Simmons citrate agar within 3 days.
d Positive after 24 h.
e Positive after 5 days.
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27). By using the method described here, urea hydrolysis was
either positive within 24 h or negative after 2 days in all spe-
cies investigated, except for N. nova, which exhibited variable
results ranging from positive within a few hours to negative
after more than 3 days.
Casein hydrolysis and gelatin hydrolysis were parallel, but
positive results with the former were usually achieved after
24 h of incubation and clearing of the medium was clear-cut.
Casein hydrolysis was positive only in N. brasiliensis and
N. pseudobrasiliensis. The latter has not been isolated during
this study, but the type strain was positive, in our hands, after
5 days in contrast to the rapid clearing by N. brasiliensis. Pos-
itivity within 24 h may therefore suggest N. brasiliensis in an
initial screening procedure.
Citrate was assimilated by several species on identification
systems using AUX medium (bioMe´rieux), e.g., N. abscessus,
N. brasiliensis, and N. asteroides (type strain). However, in this
study, alkalinization of Simmons citrate agar slants within 1 to
3 days was observed only in N. abscessus and in some rare
species, such as N. asiatica and the type strain of N. puris,
whereas the type strain of N. transvalensis was weakly positive
after 3 to 4 days. The N. brasiliensis strains were negative
except for two strains which exhibited slight and delayed alka-
linization after more than 6 days. Therefore, rapid alkaliniza-
tion of Simmons citrate agar was highly suggestive of N. ab-
scessus, since only this species and the one strain of N. asiatica
in this study were positive within 2 days among our 86 clinical
isolates.
Similarly, rhamnose acidification on LPPR agar was not
equal to rhamnose assimilation on AUX medium, for example
in the API ID 32 C system. Using our method, acid production
from rhamnose after overnight incubation occurred only in
N. farcinica among the PYR-positive isolates. Only one out of
39 strains (including the type strain) of N. farcinica did not
acidify rhamnose, even after prolonged incubation, but this
strain did not assimilate rhamnose in the API ID 32 C system
either. Other species, such as N. abscessus, may assimilate
rhamnose, but in our study, they did not acidify it on LPPR
agar, although the type strain was weakly positive after 1 or 2
days.
Although -glucosidase was positive within 4 h in most spe-
cies, the test was often weakly positive or even negative after
this incubation time in N. nova strains, but all were positive
after overnight incubation. Therefore, against the manufactur-
er’s recommendations, the test was read again after 18 to 24 h.
After this prolonged incubation time, only N. paucivorans and
N. carnea were consistently negative.
-Mannosidase was rapidly positive in all N. brasiliensis
strains, confirming the results of Biehle et al. (1). However, we
found that this enzyme was also present in the type strain of
N. pseudobrasiliensis and in the type strain of N. transvalensis.
PYR and, to a lesser extent, -GLU were key tests in the
initial screening of Nocardia species and even in the identifi-
cation of the common clinical isolates. An advantage of these
enzymatic reactions was the short incubation time with results
being achieved within 4 h. Therefore, some species may be
discarded, and the results of further investigations may be
more accurate. PYR gave clear-cut results, and the test was
positive in two common species, N. farcinica and N. nova,
accounting together for about two-thirds of our isolates. These
findings were in agreement with those reported by Biehle et al.
(1). -GLU separated the two species, which could be presum-
ably identified the same day.
DISCUSSION
When full-length sequences or partial sequences of more
than 1,000 nucleotides are analyzed, 16S rRNA gene sequenc-
ing is considered a reliable tool for species identification in the
genus Nocardia (5, 18).
It is noteworthy that 83 (96.5%) of our 86 clinical isolates
belong to only six species, whereas more than 30 species have
been validly described in 2003 (18). Since that time, several of
the new species are represented by only one strain or a few
strains, so their occurrence in humans still has to be assessed
(6, 8, 11, 12, 17, 28).
In our survey, N. farcinica outnumbers all other species,
accounting for about 44% of the isolates, followed by N. nova
and N. cyriacigeorgica. N. abscessus and N. brasiliensis are less
frequently found. N. paucivorans, represented by two strains,
has only seldomly been isolated from humans (5, 26). From the
three single isolates, N. carnea has only rarely been reported as
a pathogen in humans (5), while N. asiatica and N. niigatensis
have been described quite recently (8, 11). It should also be
noted that no N. asteroides isolates sensu stricto (type strain
cluster) have been collected during this protracted survey in
Belgium. However, the small number of strains in some species
and the limited geographical area where the study was carried
out do not permit extrapolation of this distribution to other
countries.
There are only a few reports dealing with the distribution of
Nocardia species in clinical isolates using the present nomen-
clature. One reason may be the recent changes in taxonomy
and the subdivision of the previous “N. asteroides complex”
into several new species (18). Indeed, in most cases, the “N.
asteroides complex” is considered by several authors as an
entity without reference to newly described species, such as
N. abscessus or N. cyriacigeorgica (7, 16, 19).
Kageyama et al. (10) reported 303 cases of nocardiosis in
Japan between 1992 and 2001. About 72% of the strains be-
longed to the “N. asteroides group,” including 81 strains of N.
farcinica, which was the most frequent isolate, in agreement
with our findings. It was followed by N. asteroides, N. nova, and
N. cyriacigeorgica. Besides the “N. asteroides group,” the main
species was N. brasiliensis with 66 strains (10).
In the study carried out by Saubolle and Sussland (19) in the
United States, only 34 of 455 isolates were reported to be
N. farcinica, while 319 belonged to “the N. asteroides complex.”
These figures are in sharp contrast with our findings, but the
species distribution within the “N. asteroides complex” is not
related in detail and might include N. farcinica. Moreover, the
authors emphasize the possibility of geographic variations (19).
Identification of Nocardia species by phenotypic character-
ization is often considered tedious and difficult and requires, at
least for some tests, long incubation times. Besides the decom-
position of tyrosine, xanthine, and hypoxanthine, it is mainly
based on some conventional tests, such as urea hydrolysis,
growth at 45°C, and assimilation of organic compounds on
minimal media, such as the AUX medium used in the API ID
32 C system (15, 18). Susceptibility to some antibiotics has
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been proposed to subdivide the previous “N. asteroides com-
plex,” resulting in six patterns (I to VI) (21). In another study,
a simplified battery of tests was proposed, allowing an identi-
fication within 3 to 4 days for most of the common species, but
N. asteroides type I (i.e., N. abscessus) and type VI (i.e., N. cyri-
acigeorgica) remain difficult to distinguish (13). To overcome
these difficulties, molecular methods have been proposed, re-
sulting in a more reliable and rapid identification (14). Cloud
et al. compared conventional and molecular methods and
showed that with the Microseq 500 system, the average iden-
tification time dropped from 2 to 3 weeks to 1 to 3 days (4).
Enzymatic reactions in Nocardia were studied by Boiron and
Provost using the API ZYM system (2). However, the species
nomenclature in use at that time prohibits comparison with
today’s results. Moreover, pyrrolidonyl aminopeptidase and -
glutamyl aminopeptidase are not included in the system used
by these authors. It should also be noted that results of some
enzymatic reactions, particularly -glucosidase and -man-
nosidase, may vary according to the conjugate of the sub-
strate: nitrophenyl compounds (Rosco) may be more sensitive
than naphthyl compounds present in the API ZYM system
(23). Biehle et al. (1) described an identification scheme for
five Nocardia species based on conventional tests and enzy-
matic reactions. The Microscan panels ANA and HNID were
used, containing chromogenic substrates, e.g., nitrophenyl
compounds for -glucosidase and -mannosidase and -naph-
thylamide compounds for aminopeptidases, similar to our sub-
strates, but readings were made after overnight incubation.
They found that several enzymatic reactions are discriminat-
ing, and the total identification time for the five species was, on
average, 5 days (1).
The small number of species involved in 96.5% of the iso-
lates in our study would facilitate a simplified approach to
routine identification of the most relevant species in the labo-
ratory. In the scheme we propose, we have tried to select tests
with short incubation times and which are easy to perform in
the clinical laboratory. One of the drawbacks of Nocardia iden-
tification is the difficulty to obtain a homogeneous and/or stan-
dardized inoculum. Some authors use glass beads or other
devices for this purpose (13). Even when using such methods,
a fine particulate suspension is obtained, but some species,
particularly N. brasiliensis and N. abscessus, are very difficult to
resuspend (13). In our study no attempt was made to homog-
enize the inoculum to keep the test suitable for routine use, but
a large inoculum size was used. It was roughly assessed visually,
and a heavily loaded loop of bacteria was suspended in 0.5 ml
of medium or water.
As can be seen in Table 1, only two identification profiles are
shared by more than one species. N. nova is similar to N. vet-
erana and N. africana. This is not surprising, since the three
species are considered members of the “N. nova complex” (5).
N. niigatensis also exhibits the same profile. However, this spe-
cies can be easily differentiated by its resistance to imipenem,
an uncommon feature in Nocardia, which is never present in
N. nova. The N. niigatensis strains are also resistant to ampi-
cillin and susceptible to piperacillin, while N. nova strains have
the opposite pattern. N. carnea resembles N. paucivorans. How-
ever, the N. paucivorans strains grew at 45°C and the N. carnea
FIG. 1. Algorithm for the identification of the six most relevant species isolated in this study.
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strains did not, in agreement with the findings of Roth et al.
(18). It should be noted that our clinical isolate of N. carnea
produced acid from rhamnose, whereas the three reference
strains did not. Moreover, two other species, N. abscessus and
N. asiatica, have very similar profiles in the proposed scheme,
although the two N. asiatica strains (including the type strain)
produced acid from rhamnose within 24 h, whereas all N. ab-
scessus strains did not acidify this sugar even after several days,
except for the type strain, which exhibited a weak positive
reaction after 1 or 2 days. Furthermore, N. abscessus strains are
very susceptible to amoxicillin-clavulanate, while N. asiatica
strains are more resistant.
On the basis of a few rapid tests here described, an algorithm
was constructed for the screening of the common species en-
countered in this survey (Fig. 1). It should be emphasized that
the proposed identification scheme cannot be used for taxo-
nomic purposes, since only a limited number of species have
been studied. More extensive characterization based on exist-
ing schemes and molecular methods should be performed to
identify the Nocardia species less commonly occurring in hu-
mans. Nevertheless, 96.5% of the 86 strains isolated during this
study could be identified by this method, and this was achieved
within 4 h for three species, N. farcinica, N. nova, and N. bra-
siliensis, accounting for more than 73% of our isolates. There-
fore, it could be helpful for routine use in the clinical labora-
tory, either as screening or even as rapid identification of the
most common species.
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